北京协和医学院医学博士,副主任技师,四川大学华西医院实验医学科生化室技术组长,从事临床生化和激素检验工作。主要研究方向为糖脂代谢紊乱与动脉粥样硬化性心血管病,包括血脂检测如LDL-C检测的一致性研究;脂蛋白亚组份检测的临床价值研究;载脂蛋白糖基化修饰参与动脉粥样硬化发展的机制等。
中国医师协会检验医师分会临床生物化学学组组员
中国老年医学学会检验医学分会委员
四川省微循环与血液流变学专委会青年委员会副主任委员
承担国家自然科学基金一项,四川省科技厅课题两项,成都市科技局课题一项。以第一作者和通讯作者发表国际期刊论文20余篇。
(1) Jiang Q, Feng B, Zhao Y, Ren X, Dong C, Zhou R, Yang S, Gan W(通讯作者). Proatherogenic changes in the quantity and quality of lipoproteins in adults with idiopathic nephrotic syndrome. Clin Chim Acta. 2025 Mar 15;570:120206.
(2) Zhao Y, Zhang H, Liang S, Wang Y, Gan W(通讯作者). Spurious dyslipidemia due to paraprotein in a patient with Waldenström macroglobulinemia. Clin Chim Acta. 2024 Sep 15;563:119900.
(3) Zhao A, Liu Y, Xia J, Huang L, Lu Q, Tang Q, Gan W(通讯作者). Establishment and validation of a prognostic model based on common laboratory indicators for SARS-CoV-2 infection in Chinese population. Ann Med. 2024 Dec;56(1):2400312.
(4) Zheng C, Zhou W, Zhou R, Zhang H, Liang S, Zhang W, Li G, Zhang C, Gan W(通讯作者). The necessity for improving lipid testing reagents: A real world study. Clin Chim Acta. 2023 Aug 1;548:117529.
(5) Zhao Y, Xia J, He H, Liang S, Zhang H, Gan W(通讯作者). Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease. Front Endocrinol (Lausanne). 2022 Nov 28;13:981196.
(6) Zhao Y, Wang S, Liang S, Zhang H, Zhang Y, Yu R, Zhang K, Huang H, Dong J, Gan W(通讯作者). Clinical laboratory characteristics of patients with obstructive jaundice accompanied by dyslipidemia. Clin Biochem. 2021 Aug;94:42-47.
研究生部公众号